Clinical Trials Directory

Trials / Terminated

TerminatedNCT01351844

The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer

Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
George Washington University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients have been asked to participate in the CEASE study because their treating oncologist has recommended that they start an aromatase inhibitor medication. These medications are associated with joint complaints. The purpose of this study is to see whether a computer-based educational module is a feasible intervention to help address these symptoms. If the patients agree to participate, a research coordinator will test their grip strength and give them a computer log-on code. They will be shown how to log-on to complete the educational module and a few simple questionnaires. Patients have the option to do this from home if they wish. In 3 months time, the investigators will ask patients to return to the clinic and have another grip strength evaluation and complete some additional questionnaires. The computer module and the follow up visit will each take about 30 minutes of time.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEducation and exercise interventionAn occupational therapist who has clinical experience in hand therapy for breast cancer patients with arthralgia syndrome, will review 4-5 exercises which improve hand range of motion and reduce hand stiffness.
BEHAVIORALEducation and General ExerciseA physical therapist with experience in treating breast cancer patients with lymphedema will demonstrate a series of 4-5 general stretching and toning exercises.

Timeline

Start date
2011-05-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2011-05-11
Last updated
2017-08-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01351844. Inclusion in this directory is not an endorsement.